SCHEMBL14780754

SCHEMBL14780754

O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)c1ncccc1CCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 9/20 0.46
AURKB Q96GD4 9/20 0.46
CDK1 P06493 8/20 0.46
CCNB1 P14635 8/20 0.46
CDK2 P24941 7/20 0.46
PDPK1 O15530 1/20 0.41
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
SIRT1 Q96EB6 1/20 0.38
KIT P10721 1/20 0.38
FGFR1 P11362 3/20 0.38
FGFR2 P21802 3/20 0.38
FGFR3 P22607 3/20 0.38
KDR P35968 2/20 0.38
BMPR1B O00238 1/20 0.38
CDC7 O00311 1/20 0.38
PLK4 O00444 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16229464 0.90 AURKA (0.48) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8302951 0.89 AURKA (0.47) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8305221 0.88 AURKA (0.47) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL16478930 0.85 CDK2 (0.62) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8302955 0.83 AURKA (0.47) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8302954 0.83 AURKA (0.47) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8305747 0.83 NPC1 (0.51) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL16229465 0.83 AURKA (0.48) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8300911 0.82 AURKA (0.49) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL1646037 0.82 AURKA (0.49) AURKAAURKBCDK1CCNB1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399442-B2 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED (GB) 2013-03-19 US disclosed
US-8399442-B2 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED (GB) 2013-03-19 US disclosed